Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS)
Open Access
- 1 October 2021
- journal article
- research article
- Published by Elsevier BV in World Allergy Organization Journal
- Vol. 14 (10), 100594
- https://doi.org/10.1016/j.waojou.2021.100594
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82070033)
This publication has 32 references indexed in Scilit:
- CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukastBritish Journal of Clinical Pharmacology, 2012
- Psychiatric adverse drug reactions reported during a 10‐year period in the Swedish pediatric populationPharmacoepidemiology and Drug Safety, 2011
- When to publish measures of disproportionality derived from spontaneous reporting databases?British Journal of Clinical Pharmacology, 2011
- Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance databaseBritish Journal of Clinical Pharmacology, 2011
- Selected control events and reporting odds ratio in signal detection methodologyPharmacoepidemiology and Drug Safety, 2010
- Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor responsePharmacogenetics and Genomics, 2009
- Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare eventsStatistics in Medicine, 2005
- The role of data mining in pharmacovigilanceExpert Opinion on Drug Safety, 2005
- A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiology and Drug Safety, 2002
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety, 2001